Is Conflicting Earnings Signals And Brighter Estimates Altering The Investment Case For Teladoc Health (TDOC)?

Simply Wall St.

Jun 14

In the past week, Teladoc Health drew attention as analysts projected a year-over-year earnings decline of 26.32% ahead of its forthcoming report, while recent estimate revisions pointed to healthier ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2643249997"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2643249997\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2643249997?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-06-14 17:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643249997","market":"nz","top_or_hot":-1,"title":"Is Conflicting Earnings Signals And Brighter Estimates Altering The Investment Case For Teladoc Health (TDOC)?","media":"Simply Wall St.","content":"<div>\n<p>In the past week, Teladoc Health drew attention as analysts projected a year-over-year earnings decline of 26.32% ahead of its forthcoming report, while recent estimate revisions pointed to healthier ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-conflicting-earnings-signals-and-brighter-estimates-alter\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Conflicting Earnings Signals And Brighter Estimates Altering The Investment Case For Teladoc Health (TDOC)?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Conflicting Earnings Signals And Brighter Estimates Altering The Investment Case For Teladoc Health (TDOC)?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-14 17:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-conflicting-earnings-signals-and-brighter-estimates-alter><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the past week, Teladoc Health drew attention as analysts projected a year-over-year earnings decline of 26.32% ahead of its forthcoming report, while recent estimate revisions pointed to healthier ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-conflicting-earnings-signals-and-brighter-estimates-alter\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-conflicting-earnings-signals-and-brighter-estimates-alter","article_id":"2643249997","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-conflicting-earnings-signals-and-brighter-estimates-alter","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2643249997","pubTimestamp":1781428490,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In the past week, Teladoc Health drew attention as analysts projected a year-over-year earnings decline of 26.32% ahead of its forthcoming report, while recent estimate revisions pointed to healthier near-term business conditions and improving profitability expectations.\nThis combination of weaker headline earnings expectations but more constructive revisions highlights how analyst sentiment around Teladoc’s business health can shift even without clear profit growth forecasts.\nNext, we’ll...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"相互矛盾的盈利信号和更光明的预期是否会改变Teladoc Health(TDOC)的投资案例？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1.5},"content_text":"In the past week, Teladoc Health drew attention as analysts projected a year-over-year earnings decline of 26.32% ahead of its forthcoming report, while recent estimate revisions pointed to healthier near-term business conditions and improving profitability expectations. This combination of weaker headline earnings expectations but more constructive revisions highlights how analyst sentiment around Teladoc’s business health can shift even without clear profit growth forecasts. Next, we’ll examine how these more favorable analyst estimate revisions could influence Teladoc Health’s existing investment narrative and risk-reward profile. Outshine the giants: these 14 early-stage AI stocks could fund your retirement.AdvertisementTeladoc Health Investment Narrative RecapTo own Teladoc Health, you need to believe virtual care can become a core part of how patients manage both acute needs and long term chronic conditions, and that Teladoc can eventually translate that role into sustainable profitability. The latest expectation of a 26.32% year over year earnings decline keeps near term earnings risk front and center, but improving analyst revisions suggest the key short term catalyst remains any clear evidence of margin progress rather than this single data point. Against that backdrop, the recent announcement that Teladoc’s virtual urgent care, dermatology, and nutrition services are now offered through Walmart’s Better Care Services platform looks particularly relevant. It speaks directly to Teladoc’s effort to widen consumer access and visit volumes, a critical catalyst for offsetting BetterHelp and chronic care pressures, even as execution, competition, and the economics of cash pay versus insurance models remain important open questions. Yet beneath these promising partnerships, a less obvious risk around BetterHelp’s shift toward lower margin insurance based revenue is something investors should be aware of, because it... Read the full narrative on Teladoc Health (it's free!)Teladoc Health's narrative projects $2.6 billion revenue and $164.1 million earnings by 2029. This assumes fairly flat yearly revenue growth and an earnings increase of about $364 million from -$200.3 million today.Uncover how Teladoc Health's forecasts yield a $7.12 fair value, a 3% downside to its current price.Exploring Other PerspectivesTDOC 1-Year Stock Price Chart Some analysts see Teladoc far more optimistically, assuming revenue could reach about US$2.7 billion and earnings turn positive by 2029, but the latest earnings revision news may challenge those assumptions and highlights how differently you and other investors might weigh BetterHelp’s insurance transition and future margin recovery.Explore 4 other fair value estimates on Teladoc Health - why the stock might be worth as much as 87% more than the current price!Form Your Own VerdictDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Teladoc Health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free Teladoc Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Teladoc Health's overall financial health at a glance.Seeking Other Investments?Opportunities like this don't last. These are today's most promising picks. Check them out now:Uncover the next big thing with 24 elite penny stocks that balance risk and reward.Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.Find 44 companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Teladoc Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}